BIIB

Enter Symbol: 

Detailed Quote (BIIB)

Last Trade 136.80 Volume +1,394,172.00
Change-0.24 Shares255.63M
Change % -0.18% Market Cap.34970.59M
Today's High 138.50 52 Week High 138.50
Today's Low 136.19 52 Week Low 83.83
Bid 84.00 EPS 5.09
Ask139.87 P/E Ratio 26.8762
Open137.77 Div. Per Share n.a
Previous Close137.04 ExchangeNasdaq
Intraday chart

Related News

May 16, 2012
Watch for Continued Gains in Shares of Biogen Idec (BIIB)

Biogen Idec (NASDAQ:BIIB) traded at a new 52-week high today of $137.94. So far today approximately 95,000 shares have been exchanged, as compared to an average 30-day volume of 1.1 million shares.

Biogen...

May 16, 2012
Relatively Low Projected Earnings Growth Detected in Shares of Emergent Biosolutions in the Biotechnology Industry (EBS, BIIB, AMGN, MYGN, SSRX)

Below are the three companies in the Biotechnology industry with the lowest projected earnings growth. The growth of earnings per share (current fiscal year estimated vs. last year actual) is important to gauge future profitability and relative...

May 15, 2012
41.6% Return Seen to Date on SmarTrend Biogen Idec Call (BIIB)

SmarTrend identified an Uptrend for Biogen Idec (NASDAQ:BIIB) on September 14th, 2011 at $96.76. In approximately 8 months, Biogen Idec has returned 41.64% as of today's recent price of $137.04.

Over the...

May 14, 2012
Biogen Idec Earnings In Retrospect: Up 3.6% in the Last 13 Days (BIIB)

13 days ago, on May 1st, 2012, Biogen Idec (NASDAQ:BIIB) reported its earnings. Analysts, on average, expected earnings of $1.48 per share on sales of $1.3 billion. The company actually reported EPS of $1.40 on...

May 11, 2012
Watch for Biogen Idec to Potentially Pullback After Gaining 1.79% Yesterday

Biogen Idec (NASDAQ:BIIB) traded in a range yesterday that spanned from a low of $134.23 to a high of $137.50. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $134.74 on...

May 11, 2012
Biogen Idec Set to Possibly Pullback After Yesterday's Rally of 1.79%

Biogen Idec (NASDAQ:BIIB) traded in a range yesterday that spanned from a low of $134.23 to a high of $137.50. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $134.74 on...

May 11, 2012
Shares of Biogen Idec Has Risen Above Previous 52-Week High

Shares of Biogen Idec (NASDAQ:BIIB) traded today at $136.50, breaking its 52-week high. This new high was reached on below average trading volume as 245,000 shares traded hands, while the average 30-day volume...

May 8, 2012
35.4% Return Seen to Date on SmarTrend Biogen Idec Call (BIIB)

SmarTrend identified an Uptrend for Biogen Idec (NASDAQ:BIIB) on September 14th, 2011 at $96.76. In approximately 8 months, Biogen Idec has returned 35.38% as of today's recent price of $130.99.

Biogen Idec...

May 8, 2012
Biogen Idec Crosses Below its 10-day MA (BIIB)

Biogen Idec (NASDAQ:BIIB) crossed under its 10-day moving average of $132.36 on a volume of 279K shares. Swing traders may find an opportunity for a short position, as such a crossover often suggests lower prices...

May 7, 2012
Top 5 Companies in the Biotechnology Industry With the Highest Free Cash Flow Per Share (BIIB, AMGN, GILD, MNTA, UTHR)

Below are the three companies in the Biotechnology industry with the highest free cash flow per share. FCF/share is a valuable metric signaling a company's ability to facilitate growth in the business.

Biogen Idec ranks highest with a FCF...